Veracyte, Inc.
VCYT
$26.66
-$0.03-0.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.83% | -66.26% | 164.30% | 407.62% | 93.41% |
| Total Depreciation and Amortization | -14.25% | 6.38% | 2.44% | 2.65% | -11.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.96% | 92.42% | -26.66% | 21.31% | -71.90% |
| Change in Net Operating Assets | -266.31% | -4,515.38% | -101.57% | 125.42% | -1,699.93% |
| Cash from Operations | -78.14% | -18.15% | 1.31% | 429.86% | -157.65% |
| Capital Expenditure | 56.07% | -84.70% | 19.06% | -29.80% | 14.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -- | -- | -- |
| Cash from Investing | 4.29% | -2,314.85% | 19.06% | -196.25% | 215.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -9.10% | -73.82% | 865.09% | -56.47% | 67.49% |
| Repurchase of Common Stock | -188.67% | -50.18% | -67.31% | 66.00% | -240.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.77% | -143.83% | 93,636.36% | 98.73% | -233.95% |
| Foreign Exchange rate Adjustments | 118.45% | -374.66% | 339.34% | 43.52% | -136.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.11% | -190.49% | 42.73% | 478.65% | -150.44% |